ADVENTRX: Upcoming News Event and

301 Moved Permanently

301 Moved Permanently Very Positive Technical Analysis
Print E-mail
By M.E.Garza   
Thursday, 17 December 2009 09:45

Subscribers were alerted to this stock this morning and it traded up nicely. The good news is, it's expected to go higher in the coming days given it's important forward looking news event and undervalued price.

This company just had a presentation at the Lippert/Heilshorn Life Sciences Conference (12/15/09) (look through the slides here) and we issued a breakout alert on it early this morning to our subscribers.

They have a great looking chart and


nginx
some upcoming news events that will likely see it trading higher in the coming days- especially one that involves the submission of an NDA (new drug application) before the end of the year and two late stage programs that are promising high-return on investment.

ADVENTRX Pharmaceuticals, Inc.

(AMEX:ANX)

Cick to Open Chart

As always, do your own DD. This is an AMEX stock that trades before and after market hours.

 

Disclosure: long ANX




BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter

BioMedReports Juno Therapeutics Places JCAR015 Phase II ROCKET Trial on Clinical Hold: https://t.co/clkXqUVCZs
BioMedReports Lydia I. Beebe Joins Aemetis Board of Directors: https://t.co/oQj4y3GRPj $AMTX
BioMedReports Nemus Announces Presentation of NB1111 Impact on Intraocular Pressure (IOP) at the AAPS: https://t.co/rV2T9L6NkH $NMUS
BMR:1